• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
FDA’s Breakthrough Designation Now Includes Health Equity Provision

FDA’s Breakthrough Designation Now Includes Health Equity Provision

by Ron Shinkman | Apr 26, 2024 | Clinical Diagnostics Insider, FDA-dtet

Though not expected to drastically change the program, new component gives device makers another way to strengthen their submissions

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Advancements in Antimicrobial Susceptibility Testing: Part 2

Advancements in Antimicrobial Susceptibility Testing: Part 2

by Tyler Radke, MLS(ASCP)CM | Jan 24, 2024 | Clinical Diagnostics Insider, Emerging Tests-dtet

Several methods are being developed that improve the ability to rapidly identify organisms and report susceptibility results.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Advancements in Antimicrobial Susceptibility Testing: Part 1

Advancements in Antimicrobial Susceptibility Testing: Part 1

by Tyler Radke, MLS(ASCP)CM | Jan 2, 2024 | Clinical Diagnostics Insider, Special Focus-dtet, Testing Trends-dtet

A brief overview of antimicrobial susceptibility testing, current methods used, and new methods on the horizon.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Profiling Pathogens for Public Health

Profiling Pathogens for Public Health

by Michael Schubert, PhD | Nov 24, 2023 | Clinical Diagnostics Insider, Emerging Tests-dtet, Testing Trends-dtet

Genomic epidemiology can provide insights into pathogen transmission and evolution—and facilitate better countermeasures against infectious disease.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
The Diagnostics Pipeline: FDA Moves to Modernize 510(k) Process for New Lab Tests & Devices

The Diagnostics Pipeline: FDA Moves to Modernize 510(k) Process for New Lab Tests & Devices

by Glenn S. Demby | Oct 30, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet

The changes proposed in three new draft guidances aim to speed up the process and place less emphasis on older predicate products.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com